Literature DB >> 10758285

Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds.

J R Dimmock1, S C Vashishtha, J P Stables.   

Abstract

Various acetylhydrazones, oxamoylhydrazones and semicarbazones were prepared as candidate anticonvulsants with a view to examining the viability of a putative binding site hypothesis. Atomic charge calculations were undertaken to determine the hydrogen bonding capacities of various molecules. The biological results obtained revealed that in general the acetylhydrazones and semicarbazones afforded good protection against convulsions while the oxamoylhydrazones were significantly less active. These data suggest that terminal electron-donating groups enhanced the hydrogen bonding capabilities and anticonvulsant properties of these molecules.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10758285     DOI： 10.1016/s0223-5234(00)00123-9

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN： 0223-5234            Impact factor:   6.514


  14 in total

1.  A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models.

Authors:  Shuxing Zhang; Alexander Golbraikh; Scott Oloff; Harold Kohn; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2006 Sep-Oct       Impact factor: 4.956

2.  Spectro Analytical, Computational and In Vitro Biological Studies of Novel Substituted Quinolone Hydrazone and it's Metal Complexes.

Authors:  Narsimha Nagula; Sudeepa Kunche; Mohmed Jaheer; Ravi Mudavath; Sreekanth Sivan; Sarala Devi Ch
Journal:  J Fluoresc       Date:  2017-11-21       Impact factor: 2.217

3.  Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.

Authors:  Yeliz Demir; Feyzi Sinan Tokalı; Erbay Kalay; Cüneyt Türkeş; Pelin Tokalı; Osman Nuri Aslan; Kıvılcım Şendil; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-09-14       Impact factor: 3.364

Review 4.  Biological activities of hydrazone derivatives.

Authors:  Sevim Rollas; S Güniz Küçükgüzel
Journal:  Molecules       Date:  2007-08-17       Impact factor: 4.411

5.  Synthesis, characterization, DNA interactions, DNA cleavage, radical scavenging activity, antibacterial, anti-proliferative and docking studies of new transition metal complexes.

Authors:  Kishan Prasad Chennam; Mudavath Ravi; B Ushaiah; V Srinu; Ravi Kumar Eslavath; Ch Sarala Devi
Journal:  J Fluoresc       Date:  2015-11-06       Impact factor: 2.217

6.  Synthesis, Spectral Characterization, In-vitro Antibacterial and Antifungal Activities of Novel (2e)-Ethyl-2-(2-(2, 4-Dinitrophenyl) Hydrazono)-4-(Naphthalen-2-yl)-6-Arylcyclohex-3-Enecarboxylates.

Authors:  V Kanagarajan; J Thanusu; M Gopalakrishnan
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

7.  Crystal structure of 3-(2,2-di-bromo-acet-yl)-4-hy-droxy-2H-chromen-2-one.

Authors:  Ameni Brahmia; Afef Ghouili; Rached Ben Hassen
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-03

8.  Design, synthesis and anticonvulsant activity of some new 6,8-halo-substituted-2h-[1,2,4]triazino[5,6-b]indole-3(5h)-one/-thione and 6,8-halo-substituted 5-methyl-2h-[1,2,4]triazino[5,6-b]indol-3(5h)-one/-thione.

Authors:  Rajeev Kumar; Tejendra Singh; Hariram Singh; Sandeep Jain; R K Roy
Journal:  EXCLI J       Date:  2014-03-10       Impact factor: 4.068

9.  Design, synthesis and anticonvulsant activity of some new 5,7-dibromoisatin semicarbazone derivatives.

Authors:  Dheeraj Kumar; Vijay Kumar Sharma; Rajeev Kumar; Tejendra Singh; Hariram Singh; Amar Deep Singh; R K Roy
Journal:  EXCLI J       Date:  2013-07-11       Impact factor: 4.068

10.  Anticonvulsant potential of certain new (2E)-2-[1-Aryl-3-(1H-imidazol-1-yl)propylidene]-N-(aryl/H)hydrazinecarboxamides.

Authors:  Mohamed I Attia; Mohamed N Aboul-Enein; Aida A El-Azzouny; Yousreya A Maklad; Hazem A Ghabbour
Journal:  ScientificWorldJournal       Date:  2014-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.